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Abstract
Introduction: Leptin and adiponectin are involved in the pathogenesis of several autoimmune diseases. Very little is known about adipo-
cytokine production in autoimmune thyroid diseases. Interleukin-6 (IL-6) plays an important role in the inflammatory and autoimmune
processes.
Material and methods: The aim of this study was to assess the serum levels of leptin, adiponectin, and IL-6 in postmenopausal euthyroid
women with Hashimoto’s thyroiditis and compared them with concentrations in control women.
Ninety-eight euthyroid women with Hashimoto’s thyroiditis were enrolled in the study. The diagnosis was confirmed with elevated
thyroid peroxidise autoantibody (TPOAb) levels in serum and typical hypoechogenic pattern on thyroid ultrasound. The control group,
matched for body mass index (BMI), consisted of 105 healthy postmenopausal euthyroid women. Serum levels of leptin, adiponectin, IL-6,
thyroid-stimulating hormone (TSH), free thyroxine (fT4), and TPOAbs were determined.
Results: When compared with controls, the women with Hashimoto’s thyroiditis were characterized by significantly elevated serum
concentrations of IL-6, whereas concentrations of leptin and adiponectin were not different. Hashimoto’s thyroiditis patients had signifi-
cantly higher serum levels of TSH than the controls.
The simple linear regression analyses of the Hashimoto’s thyroiditis group and all of the studied women indicated that serum leptin levels
correlated positively with BMI, waist to hip ratio (WHR), TSH, and IL-6 and negatively with adiponectin. No correlation was observed between
serum adiponectin and TSH, fT4, or TPOAbs. There were no associations between serum IL-6 levels, TPOAbs, and TSH levels; however,
positive correlations between IL-6 and BMI, WHR, and leptin were observed. TSH correlated positively with leptin, age, and TPOAbs.
Conclusions: Hashimoto’s thyroiditis is characterized by an increased production of IL-6 but does not have a direct influence on leptin or
adiponectin serum levels. The correlations between TSH and leptin demonstrated in this study highlight the need for future investiga-
tions. (Pol J Endocrinol 2010; 61 (1): 112–116)
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Streszczenie
Wstęp: Leptyna i adiponektyna odgrywają rolę w patogenezie wielu chorób o podłożu autoimmunologicznym. Niewiele wiadomo na
temat produkcji adipocytokin w autoimmunologicznych schorzeniach tarczycy. Udowodniony jest udział interleukiny-6 (IL-6, interleukin 6)
w procesach zapalnych i autoimmunologicznych.
Celem pracy była ocena stężenia leptyny, adiponektyny i IL-6 u kobiet po menopauzie z chorobą Hashimoto i porównanie ze stężeniami
u kobiet z grupy kontrolnej.
Materiał i metody: Dziewięćdziesiąt osiem kobiet z chorobą Hashimoto, będących w stadium eutyreozy, tworzyło grupę badaną. Rozpo-
znanie stawiano na podstawie podwyższonego miana przeciwciał antyperoksydazowych (TPOAb, thyroid peroxidise autoantibodies) i typo-
wego obrazu ultrasonograficznego gruczołu tarczycowego. Grupę kontrolną, dobraną pod względem wskaźnika masy ciała (BMI, body
mass index), stanowiło 105 zdrowych kobiet po menopauzie. Oceniano stężenia leptyny, adiponektyny, IL-6, hormonu tyreotropowego
(TSH, thyroid-stimulating hormone), wolnej tyroksyny (fT4, free thyroxine) oraz TPOAb.
Wyniki: Średnie stężenie IL-6 u kobiet z chorobą Hashimoto było wyższe niż u kobiet z grupy kontrolnej, natomiast nie stwierdzono
różnic w stężeniach leptyny i adiponektyny. W grupie badanej średnie stężenie TSH było wyższe niż w grupie kontrolnej. Stężenie
leptyny, zarówno w grupie badanej, jak i wśród wszystkich kobiet razem, dodatnio korelowało z BMI, wskaźnikiem talia–biodro (WHR,
waist to hip ratio), TSH, IL-6 oraz ujemnie z adiponektyną. Nie stwierdzono zależności pomiędzy adiponektyną, TSH, fT4 oraz TPOAb.
Dodatnią korelację wykryto między stężeniami IL-6 oraz BMI, WHR i leptyną, natomiast nie wykazano powiązań ze stężeniami TPOAb.
Stężenie TSH dodatnio korelowało z wiekiem oraz stężeniem TPOAb i leptyny.
Wnioski: Choroba Hashimoto sprzyja zwiększonemu wydzielaniu IL-6, natomiast nie wiąże się ze zmienioną produkcją leptyny i adipo-
nektyny. Wykazana zależność pomiędzy wydzielaniem TSH i leptyny wymaga potwierdzenia w dalszych badaniach.
(Endokrynol Pol 2010; 61 (1): 112–116)
Słowa kluczowe: choroba Hashimoto, leptyna, adiponektyna, interleukina-6
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Introduction
Autoimmune diseases affect 5–10% of the population
and are characterized by an overactive immune respon-
se of the body related directly against its own tissues,
causing prolonged inflammation. Endocrine autoimmu-
ne diseases include Hashimoto’s thyroiditis, Graves’ di-
sease, and type 1 diabetes mellitus. Hashimoto’s thyro-
iditis is the most common autoimmune thyroid disor-
der, with a higher prevalence in postmenopausal wo-
men. Different genetic and environmental factors are
involved in the pathogenesis, including iodine and se-
lenium intake, bacterial and viral infections, cytokine
therapy, stress, female sex, and age.
There is evidence for crosstalk between adipose tissue
and the immune system. Proper production of adipocy-
tokines is needed to keep optimal immune responses. Over-
-nutrition has been found to increase the risk of autoim-
mune diseases and, conversely, undernutrition has been
associated with impairment of cell-mediated immunity [1].
Leptin and adiponectin, adipocyte-derived proteins,
have immunoregulatory properties and they control
immune responses and inflammation. These adipocyto-
kines play an important role in the pathogenesis of seve-
ral autoimmune diseases such as rheumatoid arthritis,
type 1 autoimmune hepatitis, lupus erythematosus, type
1 diabetes mellitus, and autoimmune encephalomyelitis
[2–6]. However, very little is known about adipocytoki-
nes production in autoimmune thyroid diseases. We have
previously found elevated levels of adiponectin in Gra-
ves’ disease, and hyperadiponectinemia was related to
hyperthyroidism and to TSH-R antibodies [7]. To the best
of our knowledge, the problem regarding relationships
between adipocytokines and Hashimoto’s thyroiditis has
not been discussed in literature.
Interleukin-6 (IL-6) has been proposed as a marker
of inflammatory status. There is evidence of overpro-
duction of IL-6 in obesity [8] and autoimmune diseases
such as rheumatoid arthritis [9], systemic lupus erythe-
matosus [10], allergic uticaria [11], and Crohn’s disease
[12]. Among thyroid autoimmune diseases, increased
IL-6 levels have been observed in Graves’ disease [13],
in subacute thyroiditis, and in amiodarone-induced thy-
rotoxicosis [14]. The role of this cytokine in Hashimo-
to’s thyroiditis remains unclear. IL-6 regulates growth
and differentiation of thyroid cells and its expression in
thyreocytes correlates positively with the degree of lym-
phocyte infiltration [15].
The aim of the present study was to assess the se-
rum levels of adiponectin, leptin, and IL-6 in postme-
nopausal women with Hashimoto’s thyroiditis and to
compare them with healthy postmenopausal women
in the control group. To eliminate the influence of hy-
pothyroidism on serum concentrations of adipocytoki-
nes and IL-6 we selected only euthyroid women for the
study.
Material and methods
Ninety-eight euthyroid women with Hashimoto’s thy-
roiditis were enrolled in the study. They were recru-
ited from patients visiting endocrinological clinics for
routine check-ups. The diagnosis was confirmed with
elevated thyroid peroxidise autoantibody (TPOAb) le-
vels in serum and typical hypoechogenic pattern on
thyroid ultrasound. Thyroid function was assessed by
measuring serum thyroid-stimulating hormone (TSH).
Only women with TSH greater than 0.4 and less than
4.5 mIU/L were enrolled into the study. Smokers and
women with diabetes mellitus or coronary artery dise-
ase were excluded from the study. The control group,
matched for BMI, consisted of 105 healthy postmeno-
pausal euthyroid women, with TPOAbs in normal ran-
ge, with normal physical and ultrasonographic thyroid
examination and with no familiar predisposition to au-
toimmune thyroiditis. Subjects were accepted for par-
ticipation in the study after completing a medical eva-
luation (medical history, physical examination). BMI
was calculated as the ratio of weight to the square of
height, and WHR was calculated by dividing the cir-
cumferences of the waist and hip. Venous fasting blo-
od samples were obtained. Sera were frozen at –70oC
for later determination. The study was approved by the
Ethics Committee of the Silesian Medical University
(Katowice, Poland).
Serum levels of leptin and adiponectin were deter-
mined by RIA method using commercial assays (Linco
Research). Serum concentrations of IL-6 were assessed
by ELISA method (R & D Systems). TSH and free thy-
roxine (fT4) were measured by RIA method (ZenTech
SA) and normal ranges were from 0.8 to 1.8 ng/ml for
fT4, and from 0.4 to 4.5 uIU/ml for TSH. TPOAbs were
determined by RIA kit (Immunotech); the test was po-
sitive for values > 20 IU/ml. Measurements were made
at the endocrinology clinic immunology laboratory. The
intra- and interassay coefficients of variation (CVs) were
less than 10%. Results are given as mean ± SD for nor-
mally distributed data or median plus (25th; 75th) per-
centiles for non normal distribution in W Shapiro-Wil-
ka test. For comparisons between groups, t test or Mann-
Whitney U test were used. It was assumed that the
difference was significant at p<0.05. Spearman’s corre-
lation coefficients were used to estimate linear relation-
ships between variables. Statistical analysis was perfor-
med using Statistica 7.1 package, StatSoft Inc., Tulsa,
USA.
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Results
The characteristics of the study groups are shown in
Table I. When compared with controls, the women with
Hashimoto’s thyroiditis were characterized by signifi-
cantly elevated serum concentrations of IL-6, whereas
concentrations of leptin and adiponectin were not dif-
ferent. Hashimoto’s thyroiditis patients had significan-
tly higher serum levels of TSH than controls, but no
difference in fT4 was found.
The simple linear regression analyses of Hashimo-
to’s thyroiditis group and all of the studied women in-
dicated that serum leptin levels correlated positively
with BMI, WHR, TSH, and IL-6 and negatively with
adiponectin. No correlation was observed between se-
rum adiponectin and TSH, fT4, or TPOAbs. There were
no associations between serum IL-6 levels, TPOAbs, and
TSH levels; however, positive correlations between IL-6
and BMI, WHR, and leptin were observed. TSH corre-
lated positively with age, TPOAbs, and leptin (Fig.1).
The results of regression analyses for the Hashimoto’s
thyroiditis group are presented in Table II.
Discussion
Hashimoto’s thyroiditis is a localized autoimmune di-
sease which is characterized by the production of the
antibodies against thyroid auto-antigens and infiltra-
tion of cytotoxic T cells in the thyroid gland leading to
the destruction of follicles. Different cytokines released
by immune cells cause thyroid cell damage and are in-
volved in inflammatory processes. Diseased thyroids
exhibit enhanced expression of IL-6 [16], which indu-
ces monocyte chemoattractant protein-1 (MCP-1) pro-
Table I. Clinical and biochemical characteristic of postmenopausal women with Hashimoto’s thyroiditis and of the control
women
Tabela I. Porównanie parametrów klinicznych i biochemicznych w grupie kobiet po menopauzie z chorobą Hashimoto
i w grupie kontrolnej
Hashimoto’s thyroiditis women Control group p
 n = 98 n = 105
Age (years) 58.41 ± 6.20 57.35 ± 6.81 NS
BMI [kg/m2] 28.38 ± 10.86 28.02 ± 9.45 NS
WHR 0.84 ± 0.05 0.84 ± 0.06 NS
Adiponectin [mg/ml] 18.71± 8.73 19.03 ± 7.94 NS
Leptin [ng/ml] 23.39± 13.42 24.05 ± 10.82 NS
IL-6 [pg/ml] 5.51 [3.34; 6.72] 3.26 [2.58; 4.81] <0.01
TSH [mIU/ml] 3.12 ± 1.27 2.26 ± 1.16 <0.01
fT4 [ng/dl] 1.2 ± 0.53 1.3 ± 0.46 NS
TPOAb [mIU/ml] 210 [63; 315] 10.35 [6.76; 17.42] <0.001
Normally distributed data are given as mean ± SD. Skewed data are given as median plus [25th; 75th] percentiles. The significance tests used are the
Mann-Whitney U test for not normally distributed variables and unpaired t test for normally distributed variables
Figure 1. Relationship between serum TSH and leptin in the
Hashimoto’s thyroiditis group
Rycina 1. Korelacje między stężeniem TSH i leptyny u kobiet
z chorobą Hashimoto
duction in follicular cells [17] and enhances lymphocy-
te infiltration in goitrous [15]. IL-6 is produced by B and
T lymphocytes (mainly Th-2 cells) as well as by diffe-
rent cells including macrophages and fibroblasts. IL-6
is involved in B-cell activation into antibody-producing
cells, proliferation, maturation and in the cytotoxic
differentiation of T-cells. In Hashimoto’s thyroiditis,
deficient functioning of T cells and an imbalance of Th-
1/Th-2 cells predominantly expressing Th-1 have been
reported [16]. A number of studies have demonstrated
that IL-6 concentrations are elevated in the peripheral
circulation of patients with autoimmune diseases such
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as rheumatoid arthritis [9], systemic lupus erythemato-
sus [10], and allergic uticaria [11]. To date there have
been only a few studies regarding connections betwe-
en IL-6 and Hashimoto’s thyroiditis, and the results are
not clear. In animal experiments, IL-6 plays a minor role
in the development of thyroglobulin-induced autoim-
mune thyroiditis; however, this cytokine is not invo-
lved in iodine-induced thyroiditis [18]. In a recent stu-
dy, Rugerri et al. found increased levels of IL-6 in
Hashimoto’s thyroiditis patients [19].
The main finding of our study is that serum IL-6 le-
vels are increased in women with Hashimoto’s thyro-
iditis when compared with a control group, suggesting
that IL-6 is involved in the development of the disease.
It may be that the elevated concentration is a systema-
tic manifestation of immune activation; however, the
clinical significance of our observation is uncertain. The
chronic activation of the immune system due to Hashi-
moto’s thyroiditis can lead to impaired endothelium-
dependent vasodilation and may cause endothelial dys-
function in humans [20]. It has been shown that IL-6
promotes atherogenesis directly by endothelial-depen-
dent mechanisms and indirectly by stimulating hepatic
production of C reactive protein [21].
Although TSH levels in our Hashimoto’s females
were kept within the normal range, the studied group
was characterized by significantly higher TSH concen-
trations than the controls. It is worth noting that more
severe coronary atherosclerosis has been reported in
patients with low but clinically normal thyroid func-
tion [22]. In the HUNT Study of more than 25 000 pe-
ople, TSH levels within the reference range were posi-
tively associated with coronary heart disease in women
[23]. The authors stated that the connections might be
the result of the inflammation associated with autoim-
mune thyroiditis [24]. In our study, TSH correlated po-
sitively with leptin, and this adipocytokine promotes
atherosclerosis [2].
The second question of our study asked whether
there were any associations between IL-6 and other
analyzed parameters. Although in in vitro studies TSH
has been shown to stimulate IL-6 release from differen-
tiated adipocytes [25], in our observations there were
no correlations between IL-6 and thyroid function or
antithyroid antibodies. However, this cytokine positi-
vely correlated with BMI, WHR, and serum concentra-
tion of leptin. The results suggest the increased occur-
rence of Hashimoto’s thyroiditis in obesity; however,
in our study, the study group had a similar BMI range
as in the control group.
In the next step, we examined the serum concentra-
tions of adiponectin and leptin dependent on the pre-
sence of Hashimoto’s thyroiditis. It is well known that
adipocytokines have immunoregulatory functions and
their concentrations are elevated in the peripheral cir-
culation of patients with many autoimmune diseases
such as type 1 autoimmune hepatitis [4], rheumatoid
arthritis [6], and systemic lupus erythematosus [5]. De-
tailed mechanisms of adiponectin actions remain unk-
nown. The adipokine possesses anti-inflammatory
properties although recent studies have documented
pro-inflammatory and immunomodulatory effects.
Adiponectin activates proinflammatory transcription
factor NF-kB and ERK1/2MAPK [26], and influences
immune responses by regulating T cell activation and
suppressing B cell development. It has been reported
that the interplay between adiponectin and immune
cells plays a role in the development of autoimmune
diseases, and in these states, adiponectin correlates with
increased serum levels of leptin and IL-6 [27]. Leptin,
another adipocytokine, also influences immune cell
function. This protein promotes the proliferation and
activation of thymic T cells, and induces a switch to-
wards Th-1 cell immune responses and the suppression
of Th-2 cell responses [28]. Leptin is probably a link be-
tween nutritional status and immune function. On one
hand, leptin-deficient ob/ob mice display obesity, thy-
mic atrophy, and defects in immune reactions (innate
and adaptive) [29]. In starvation, it has been documen-
ted that low serum leptin levels are associated with im-
paired inflammatory T cell responses, and administra-
tion of leptin reverses the immunosuppressive effects
[30]. On the other hand, in obesity, decreased immu-
nological tolerance might be a consequence of changed
secretion of adipocytokines by adipose tissue. Although
overproduction of adiponectin and leptin is pathologi-
cally involved in collagen-induced inflammatory auto-
immune diseases, in the present study no difference of
Table II. Spearman«s coefficients of the relationships between
clinical and biochemical parameters in the Hashimoto’s
thyroiditis group
Tabela II. Współczynniki korelacji r Spearmana pomiędzy
ocenianymi parametrami klinicznymi i biochemicznymi
w grupie badanej
r Spearman p
Leptin & BMI 0.71 < 0.001
Leptin & WHR 0.32 < 0.001
Leptin & TSH 0.21 < 0.01
Leptin & IL-6 0.24 < 0.01
Leptin & adiponectin –0.30 < 0.001
IL-6 & BMI 0.22 < 0.001
IL-6 & WHR 0.28 < 0.001
TSH & age 0.17 < 0.05
TSH & TPOAbs 0.28 < 0.001
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serum adiponectin or leptin levels was observed with
regard to the presence of Hashimoto’s thyroiditis. This
finding suggests that the pathogenesis of autoimmune
thyroiditis is different and independent of connections
with adipose tissue.
In our study, we observed a strong positive correla-
tion between leptin and BMI and WHR, as well as posi-
tive connections with TSH and IL-6. The exact mecha-
nism mediating the relationship between leptin and
TSH remains unknown. TSH receptors have been fo-
und on several fat depots [31]. In animal experiments,
TSH directly influences adipose tissue and stimulates
adipogenesis through these receptors on the surface of
adipocytes [32]. In our study, higher levels of TSH were
detected in the studied group and they correlated posi-
tively with TPOAbs. The exact role of antibodies aga-
inst thyroid peroxidase is unclear but it is likely that
they promote the release of a variety cytokines including
IL-6, TNF-a, and IFN-g [33]. Nevertheless, we did not
find any significant correlation between concentrations
of IL-6 and TPOAbs in the peripheral circulation of
women with Hashimoto’s thyroiditis. This suggests that
the two phenomena may not be directly related to each
other. Considering the fact that high TPOAbs concen-
trations correlate with increased frequencies of Th-1 re-
sponsible for thyroid damage and the loss of thyroid
function, it can be speculated that antibodies influence
the level of TSH. Indeed, the presence of TPOAbs is
associated with increased risk of the development of
hypothyroidism in the future [34].
Conclusions
The findings presented here suggest the possible invo-
lvement of IL-6 in the pathogenesis of Hashimoto’s
thyroiditis. In contrast, the results suggest that autoim-
mune thyroiditis does not have a direct influence on
adiponectin and leptin serum levels. The correlations
between TSH and leptin demonstrated in this study hi-
ghlight the need for future investigations.
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